Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
C.GRCM | 5 hours ago VANCOUVER, BC, June 7, 2024 – Geologica Resource Corp. (CSE:GRCM, FSE:862 ) (“Geologica” or the “Company”) is pleased to announce the closing of its previously announced financing and property acquisition. The Company intends to issue 4,301,450 Units at $0.035 per unit for total proceeds of $150,550 (the “Units”) each Unit consists of a share and a whole warrant. Each warrant may be exercised for 1 (one) share for 2 (two) years from closing for $0.05. A warrant holder must exercise the Warrant, within 30 days of the shares of the Company trading at a 20 day VWAP of $0.20 or greater once the 4 month statutory hold has expired. The Company paid finders fees of $10,928 and issued 312,229 finders warrants. The warrants have the same terms as above. The proceeds of the financing will be used for exploration work and general administration. In a sperate transaction the Company issued 2,000,000 shares to complete the acquisition of the Topley West Property as announced March 28, 2024. The Company has also issued 100,000 shares at a deemed price of $0.045 to settle outstanding debt with an unrelated party. The securities issued under the financing will be subject to restrictions on resale for 4 (Four) months and a day, pursuant to applicable Canadian securities laws and the rules of the Canadian Securities Exchange. TOPLEY LANDING PROJECT TOPLEY LANDING PROJECT The claims to be explored at Topley Landing are overlapped by Lake Babine Nation (LBN) traditional territory; In consultation with the Lake Babine Nation, Geologica has been granted access to Topley for completion of an IP survey; Geochemistry has identified high priority exploration target areas and kilometer-scale VMS target areas; The region is known for its large porphyry, copper/gold, and copper/molybdenum deposits including the on-trend past-producing Granisle and Bell copper mines; American Eagle Gold Corp. has discovered a copper deposit on trend with Topley; The property is located in central BC, is road accessible and cost effective to explore year round BC Hydro power lines transect the property and several water sources are available on the property; Rail Access to tide water is only 40km away; Porphyries contain the largest reserves of Copper and close to 50% of gold reserves in BC; Topley Property consists of 11 mineral claims totaling 4,216 Ha with six known prospects and showings. About Geologica Resource Corp. Geologica Resource Corp. is a mineral explorer, building shareholder value through the acquisition of projects with significant technical merit. The Company has an option agreement and a purchase agreement for 100% of the mineral claims known as the Topley Project, located in central British Columbia. Further information on Geologica Resource Corp. can be found on the Company’s website https://geologicaresource.com/ and on SEDAR at https://www.sedarplus.ca Doug Unwin President & CEO (604) 762-5355 doug.unwin@geologicaresource.com Forward-Looking Statements This news release contains forward-looking information which is not comprised of historical facts. Forward-looking information is characterized by words such as “plan”, “expect”, “ensuring”, “believe”, “anticipate”, “will”, “would” and other similar words, or statements that certain events or conditions “may” or “will” occur. In particular, this news release contains forward-looking information pertaining to the Company’s plans and objectives with respect to the Topley Project. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, changes in the state of equity and debt markets, fluctuations in commodity prices, delays in obtaining required regulatory or governmental approvals, environmental risks, limitations on insurance coverage, failure to obtain all necessary regulatory approvals, risks and uncertainties inherent in the exploration and development of mineral properties, and other risk factors set forth in the long-form prospectus of the Company dated July 22, 2022 under the heading “Risk Factors”, a copy of which is available on the Company’s SEDAR profile at www.sedarplus.ca. Forward-looking information in this news release is based on the opinions and assumptions of management considered reasonable as of the date hereof, including, but not limited to, the assumption that general business and economic conditions will not change in a materially adverse manner. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information. The Company disclaims any intention or obligation to update or revise any forward-looking information, other than as required by applicable securities laws. Tags: INDUSTRIAL METALS & MINERALS 0 Related News @ the Bell: Resource stocks lift TSX 21 hours ago @ the Bell: How did markets react to the BoC rate cut? 1 day ago @ the Bell: TSX hits one-month low 2 days ago Recent U.S. Press Releases Geologica Closes Financing And Property Acquisition 5 hours ago INDUSTRIAL METALS & MINERALS ADDITION OF NEW COPPER CLAIMS AT TOPLEY PROJECT April 18, 2024 INDUSTRIAL METALS & MINERALS Xcyte Digital Corp. Purchases Assets of A+ Conferencing April 3, 2024 TECHNOLOGY More Press Releases » Featured News Links Flow Test and Laboratory Analysis Confirm a Major New HELIUM Discovery in Minnesota This Small-Cap Gold Stock Keeps Notching Up High-Grade Gold in Nevada Thematic Insights: Free Podcast Exploring Market Trends & Emerging Sectors Get the latest news and updates from Stockhouse on social media facebook twitter linkedin Follow STOCKHOUSE Today (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mind Medicine (MindMed) Inc
MNMD
Alternate Symbol(s):
N.MMED.WA
|
N.MMED.WR
|
N.MMED.WS
|
N.MMED
Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen...
drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MNMD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2)
•••
Robert1999
X
View Profile
View Bullboard History
Comment by
Robert1999
on Jun 06, 2024 8:27pm
RE:RE:RE:Stock Price Pressure
49.12% % of Shares Held by Institutions 50.47% % of Float Held by Institutions 161 Number of Institutions Holding Shares % was 5%, 1 month ago...very promising
(112)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on Jun 06, 2024 12:00pm
RE:Stock Price Pressure
This doesn't look great. PTSD treatment was kind of MM's thing. https://www.forbes.com/sites/roberthart/2024/06/05/psychedelic-stocks-tank-after-fda-advisors-shoot-down-mdma-therapy-for-ptsd/
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Jun 06, 2024 8:20am
Buzz on the Bullboards: 3 stocks breaking the silence of a quiet June
During this quieter month of June ahead of summer, some public Canadian companies have been engaging in serious business.
read article.
(267)
•••
sollmg
X
View Profile
View Bullboard History
Comment by
sollmg
on Jun 05, 2024 11:40am
RE:RE:Stock Price Pressure
Further searching found this on seeking alpha https://seekingalpha.com/news/4113189-rbc-recommends-buying-mindmed-amid-psychedelic-stocks-sell-off RBC recommends buying MindMed amid psychedelic
...more
(2)
•••
Robert1999
X
View Profile
View Bullboard History
Comment by
Robert1999
on Jun 05, 2024 11:21am
RE:Stock Price Pressure
100% agree It's not the time to sell
(267)
•••
sollmg
X
View Profile
View Bullboard History
Post by
sollmg
on Jun 05, 2024 10:24am
Stock Price Pressure
I looked for news to try and find a reason for the price movement. Found nothing bad. Then looked at the shorts. 22% of the float short. looks like a bear attack. Also looked at the institutional
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 04, 2024 8:01am
New Press Release - MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York
-A single oral administration of MM120 100 µg met its primary and key secondary endpoints and maintained clinically and statistically significant HAM-A reductions compared to placebo at 12 weeks with a 65% clinical response rate and a 48% clinical remission rate--MindMed also presents two new...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 02, 2024 7:08am
New Press Release - MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it plans to host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. ET to provide a...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 25, 2024 7:02am
New Press Release - MindMed to Present at Upcoming May Medical Conferences
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study of MM120 in Generalized Anxiety...
read article.
(112)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on Apr 12, 2024 3:06pm
RE:mmed
You might have to call your broker to request a transfer to NSDQ otjerwise the shares will show up in your account but the values won't and you won't be able to trade them. Only takes one to
...more
(112)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on Apr 06, 2024 9:11am
RE:mmed
They'll just get transferred. You'll still own the same amount. Your account will probably show in USD though.
(0)
•••
dave1100
X
View Profile
View Bullboard History
Post by
dave1100
on Apr 04, 2024 3:06pm
mmed
What will happen to my Canadian shares once MMED is only on the nasdaq?
(10)
•••
Bigmoneytalks
X
View Profile
View Bullboard History
Comment by
Bigmoneytalks
on Apr 03, 2024 6:50pm
RE:3 Month Predictions
Hell of a day! Big volume as well
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 02, 2024 7:07am
New Press Release - MindMed to Present at Upcoming April Medical Conferences
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present posters describing the impact that COVID has had on...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 01, 2024 5:02pm
New Press Release - MindMed Announces Voluntary Delisting from Cboe Canada
All Common shares will remain listed on Nasdaq Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it has elected to...
read article.
(10)
•••
Bigmoneytalks
X
View Profile
View Bullboard History
Post by
Bigmoneytalks
on Mar 27, 2024 4:32pm
3 Month Predictions
Not a lot of chatter on the forum... It has been a nice jump in SP the last 3 weeks and holding at current prices. What are some predictions on SP the next 3 months?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A Junior Copper-Gold Stock Trading at a Bargain of Monumental Proportions
New results add billions to Theralase's addressable market
Thematic Insights: Free Podcast Exploring Market Trends & Emerging Sectors